Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 22;54(4):371-376.
doi: 10.2478/raon-2020-0053.

Modern treatment of vulvar cancer

Sebastjan Merlo  1   2
Affiliations
Review

Modern treatment of vulvar cancer

Sebastjan Merlo. Radiol Oncol. .

Abstract

Background Vulvar cancer accounts for 3-5% of malignant diseases of the female genital tract. The Slovenian incidence rate is 5.5/100,000, which means 57 new cases per year. The most common histological type (90%) is squamous cell carcinoma. Based on etiology, it can be classified into the first type which correlates with human papillomavirus (HPV) infection and the second type which is not associated with HPV. The most common and long-lasting symptom of vulvar cancer is pruritus. The preferred diagnostic procedure to confirm the diagnosis is a punch or incision biopsy. Surgery in combination with radiotherapy is the standard treatment for vulvar cancer. Sentinel lymph node biopsy with lymphoscintigraphy is now a standard part of surgical treatment. Chemotherapy is a palliative treatment option. Conclusions Vulvar cancer is a rare disease. Because of the pathogenesis, surgery and radiotherapy are the main treatment modalities. The sentinel node biopsy (SNB) represents a contemporary approach to the vulvar cancer treatment and significantly reduces morbidity. Improvements in treatment of vulvar cancer contributed to the decrease of mortality among Slovenian women.

Keywords: lymphoscintigraphy; radiotherapy; sentinel lymph node biopsy; surgical treatment; vulvar cancer.

PubMed Disclaimer

References

    1. Alkatout I, Schubert M, Garbrecht N, Weigel MT, Jonat W, Mundhenke C. Vulvar cancer: epidemiology, clinical presentation, and management options. Int J Womens Health. 2015;7:305–13. doi: 10.2147/IJWH.S68979. et al. - DOI - PMC - PubMed
    1. Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F. European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017;27:832–7. doi: 10.1097/IGC.0000000000000975. et al. - DOI - PubMed
    1. Cancer Registry of Republic of Slovenia [Internet] 2016. https://www.onko-i.si/rrs/ [cited 2020 May 6]. Available from.
    1. Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol. 2017;51:47–55. doi:1 0.1515/raon-2017-0008. - PMC - PubMed
    1. Cancer in Slovenia. Ljubljana: Cancer in Slovenia 2016. Ljubljana: Institute of Oncology Ljubljana; 2016. https://www.onko-i.si/fileadmin/onko/datoteke/dokumenti/RRS/LP_2016.pdf Epidemiology and Cancer Registry, Slovenian Cancer Registry; [internet] 2019 [cited 2020 May 12]. Available from.